Literature DB >> 16956432

Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy.

G Valesini1, C Montecucco, M Cutolo.   

Abstract

The present report is devoted to drawing up and disseminating specific recommendations for the use of anti-TNF-alpha therapies in patients with rheumatoid arthritis (RA) in Italy. The document reports and discusses the published literature concerning the criteria for inclusion, assessment of response and for withdrawal of treatment with TNF blocking agents in RA. Several specific points concerning more sensitive warnings are discussed: tuberculosis, hepatitis, lymphoma, and cardiovascular risk and induction of autoimmunity. The recommendations are summarized in an 8-point table approved by the executive committee of the Italian Society for Rheumatology.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16956432

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  10 in total

1.  ELISPOT-IFN-gamma assay instead of tuberculin skin test for detecting latent Mycobacterium tuberculosis infection in rheumatic patients candidate to anti-TNF-alpha treatment.

Authors:  Stefania Girlanda; Paola Mantegani; Elena Baldissera; Patrizia Aiello; Manuela Ratti; Maria Grazia Sabbadini; Claudio Fortis
Journal:  Clin Rheumatol       Date:  2010-07-20       Impact factor: 2.980

2.  Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment.

Authors:  M Bocchino; A Matarese; B Bellofiore; P Giacomelli; G Santoro; N Balato; F Castiglione; R Scarpa; F Perna; G Signoriello; D Galati; A Ponticiello; A Sanduzzi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-10       Impact factor: 3.267

3.  High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register.

Authors:  Florenzo Iannone; Elisa Gremese; Gaia Gallo; Piercarlo Sarzi-Puttini; Costantino Botsios; Francesco Trotta; Stefania Gasperini; Mauro Galeazzi; Silvano Adami; Fabrizio Cantini; Marco Sebastiani; Roberto Gorla; Antonio Marchesoni; Annarita Giardina; Rosario Foti; Angiola Mele; Eleonora Bruschi; Gianluca Bagnato; Gian Luca Erre; Giovanni Lapadula
Journal:  Clin Rheumatol       Date:  2013-08-18       Impact factor: 2.980

4.  A proposal of simple calculation (ERI calculator) to predict the early response to TNF-α blockers therapy in rheumatoid arthritis.

Authors:  Laura Bazzichi; Paolo Rossi; Camillo Giacomelli; Francesca De Feo; Francesca Bobbio-Pallavicini; Alessandra Rossi; Chiara Baldini; Arianna Consensi; Marica Doveri; Claudia Bonino; Maurizio Mazzantini; Alessandra Della Rossa; Carlomaurizio Montecucco; Stefano Bombardieri
Journal:  Rheumatol Int       Date:  2010-11-26       Impact factor: 2.631

5.  Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

Authors:  Boksoon Chang; Hye Yun Park; Kyeongman Jeon; Joong Kyong Ahn; Hoon-Suk Cha; Eun-Mi Koh; Eun-Suk Kang; Won-Jung Koh
Journal:  Clin Rheumatol       Date:  2011-05-10       Impact factor: 2.980

6.  Rheumatoid arthritis and renal light-chain deposition disease: long-term effectiveness of TNF-α blockade with etanercept.

Authors:  Lorenzo Cavagna; Vincenzo Sepe; Francesca Bobbio-Pallavicini; Filippo Mangione; Roberto Caporali; Carlomaurizio Montecucco
Journal:  Int Urol Nephrol       Date:  2010-06-18       Impact factor: 2.370

7.  Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis.

Authors:  Chen Yu; Shangyi Jin; Yanhong Wang; Nan Jiang; Chanyuan Wu; Qian Wang; Xinping Tian; Mengtao Li; Xiaofeng Zeng
Journal:  Clin Rheumatol       Date:  2018-10-19       Impact factor: 2.980

8.  Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: an observational study.

Authors:  Matteo Filippini; Chiara Bazzani; Ennio Giulio Favalli; Antonio Marchesoni; Fabiola Atzeni; Piercarlo Sarzi-Puttini; Francesca Bobbio Pallavicini; Roberto Caporali; Roberto Gorla
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 9.  Induction of remission in rheumatoid arthritis: criteria and opportunities.

Authors:  Guido Valesini; Manuela Di Franco; Francesca Romana Spinelli; Rossana Scrivo
Journal:  Rheumatol Int       Date:  2008-09-21       Impact factor: 3.580

10.  Screening for latent tuberculosis before starting TNF-alpha inhibitors in a population with high BCG vaccination rates.

Authors:  Aysa Hacioglu; Sermin Borekci; Melike Melikoglu; Yesim Ozguler; Sinem Nihal Esatoglu; Serdal Ugurlu; Emire Seyahi; Izzet Fresko; Vedat Hamuryudan; Huri Ozdogan; Sebahattin Yurdakul; Ibrahim Hatemi; Aykut Ferhat Celik; H Gul Ongen; Gulen Hatemi
Journal:  Rheumatol Int       Date:  2021-07-06       Impact factor: 3.580
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.